- Home
- CRDF vs FOA Comparison
CRDF vs FOA Comparison
Compare CRDF & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- FOA
- Stock Information
- Founded
- CRDF 1999
- FOA 2013
- Country
- CRDF United States
- FOA United States
- Employees
- CRDF N/A
- FOA N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- FOA Finance Companies
- Sector
- CRDF Health Care
- FOA Finance
- Exchange
- CRDF Nasdaq
- FOA Nasdaq
- Market Cap
- CRDF 143.4M
- FOA 143.7M
- IPO Year
- CRDF N/A
- FOA N/A
- Fundamental
- Price
- CRDF $2.58
- FOA $21.28
- Analyst Decision
- CRDF Strong Buy
- FOA Strong Buy
- Analyst Count
- CRDF 3
- FOA 2
- Target Price
- CRDF $9.33
- FOA $17.00
- AVG Volume (30 Days)
- CRDF 1.1M
- FOA 55.0K
- Earning Date
- CRDF 11-07-2024
- FOA 11-06-2024
- Dividend Yield
- CRDF N/A
- FOA N/A
- EPS Growth
- CRDF N/A
- FOA N/A
- EPS
- CRDF N/A
- FOA 10.89
- Revenue
- CRDF $688,000.00
- FOA $719,526,000.00
- Revenue This Year
- CRDF $15.00
- FOA N/A
- Revenue Next Year
- CRDF N/A
- FOA N/A
- P/E Ratio
- CRDF N/A
- FOA $1.67
- Revenue Growth
- CRDF 49.57
- FOA 3011.46
- 52 Week Low
- CRDF $1.07
- FOA $4.10
- 52 Week High
- CRDF $6.42
- FOA $23.48
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- FOA 75.51
- Support Level
- CRDF $2.85
- FOA $17.05
- Resistance Level
- CRDF $4.38
- FOA $23.48
- Average True Range (ATR)
- CRDF 0.45
- FOA 2.37
- MACD
- CRDF -0.10
- FOA 0.78
- Stochastic Oscillator
- CRDF 2.70
- FOA 81.89
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to an range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.